The essentials
CDC director position vacant after Monarez's firing; Trump's nominee Schwartz undergoing Senate confirmation amid agency turmoil.
The CDC director position has experienced significant instability during the second Trump administration. Susan Monarez was fired as CDC director after less than one month in the role, leaving the agency without permanent leadership for an extended period. Dr. Erica Schwartz was nominated by Trump for the CDC director position in April 2026 and subsequently appeared before the Senate for her confirmation hearing.
The leadership turmoil has coincided with broader organizational challenges. The CDC has experienced significant staff reductions and organizational turmoil in 2025, while public trust in CDC health recommendations has dropped sharply. Additionally, Sean Kaufman appeared before the Senate for a confirmation hearing on the pandemic preparedness role.
Health Secretary Kennedy has addressed questions about his involvement in agency operations, denying directing the CDC director on vaccine policy. The confirmation process for Schwartz's nomination continues as the agency navigates these transitions.
Other ways to read this story.
Alternative framings generated by SigNews. These are not independent sources or attributed quotations.
Leadership vacuum creates operational challenges for public health agency
The CDC faces compounded difficulties from sustained leadership vacancy and staff reductions. Monarez's rapid departure created immediate instability, while the extended vacancy during the confirmation process limits the agency's operational capacity. Simultaneous organizational downsizing has strained institutional continuity and institutional memory, affecting the agency's ability to function effectively during the leadership transition.
Trump administration reshapes public health leadership through nominations and removals
The administration's approach to CDC leadership reflects broader cabinet-level changes, with Schwartz's nomination proceeding through standard Senate confirmation processes. The decision to remove Monarez and pursue new leadership represents substantive personnel changes, while related nominations like Kaufman's indicate coordinated reshaping of pandemic preparedness and health policy roles across the administration.